Oligo Bio Iodine

Wirkstoff: CHELIDONIUM MAJUS WHOLE, IODINE, LYCOPUS VIRGINICUS WHOLE, GINKGO, PINUS SYLVESTRIS LEAFY TWIG, FUCUS VESICULOSUS, SPONGIA OFFICINALIS SKELETON, ROASTED, GERMANIUM SESQUIOXIDE, SUS SCROFA PITUITARY GLAND, THYROID, CYSTEINE, MANGANESE GLUCONATE, OXOGLURIC ACID, OYSTER SHELL CALCIUM CARBONATE, CRUDE, FERROUS IODIDE, FUMARIC ACID, POTASSIUM IODIDE, SODIUM DIETHYL OXALACETATE, PULSATILLA VULGARIS WHOLE, SILVER, GOLD, COPPER, EUGENOL, FORMALDEHYDE, LIDOCAINE, MERCURIUS SOLUBILIS, MOLYBDENUM, NICKEL, PALLADIUM, TIN, TITANIUM, ZINC, RUBELLA VIRUS, MUMPS VIRUS, HUMAN COXSACKIEVIRUS A2, HUMAN COXSACKIEVIRUS A7, HUMAN COXSACKIEVIRUS B1, HUMAN COXSACKIEVIRUS B3, HUMAN COXSACKIEVIRUS B4

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · CHELIDONIUM MAJUS WHOLE 3 [hp_X]/mL, IODINE 4 [hp_X]/mL, LYCOPUS VIRGINICUS WHOLE 4 [hp_X]/mL, GINKGO 6 [hp_X]/mL, PINUS SYLVESTRIS LEAFY TWIG 6 [hp_X]/mL, FUCUS VESICULOSUS 6 [hp_X]/mL, SPONGIA OFFICINALIS SKELETON, ROASTED 7 [hp_X]/mL, GERMANIUM SESQUIOXIDE 8 [hp_X]/mL, SUS SCROFA PITUITARY GLAND 8 [hp_X]/mL, THYROID 8 [hp_X]/mL, CYSTEINE 9 [hp_X]/mL, MANGANESE GLUCONATE 10 [hp_X]/mL, OXOGLURIC ACID 12 [hp_X]/mL, OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL, FERROUS IODIDE 12 [hp_X]/mL, FUMARIC ACID 12 [hp_X]/mL, POTASSIUM IODIDE 12 [hp_X]/mL, SODIUM DIETHYL OXALACETATE 12 [hp_X]/mL, PULSATILLA VULGARIS WHOLE 12 [hp_X]/mL, SILVER 12 [hp_X]/mL, GOLD 12 [hp_X]/mL, COPPER 12 [hp_X]/mL, EUGENOL 12 [hp_X]/mL, FORMALDEHYDE 12 [hp_X]/mL, LIDOCAINE 12 [hp_X]/mL, MERCURIUS SOLUBILIS 12 [hp_X]/mL, MOLYBDENUM 12 [hp_X]/mL, NICKEL 12 [hp_X]/mL, PALLADIUM 12 [hp_X]/mL, TIN 12 [hp_X]/mL, TITANIUM 12 [hp_X]/mL, ZINC 12 [hp_X]/mL, RUBELLA VIRUS 16 [hp_X]/mL, MUMPS VIRUS 30 [hp_X]/mL, HUMAN COXSACKIEVIRUS A2 16 [hp_C]/mL, HUMAN COXSACKIEVIRUS A7 16 [hp_C]/mL, HUMAN COXSACKIEVIRUS B1 16 [hp_C]/mL, HUMAN COXSACKIEVIRUS B3 16 [hp_C]/mL, HUMAN COXSACKIEVIRUS B4 16 [hp_C]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: BioActive Nutritional, Inc.

Geprüft 2026-10-09 · openFDA NDC